Intel Corp (INTC)
22.49
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 7th, 6:13 AM EDT
The stock’s RSI is at 83, significantly over the key overbought level of 70, the analyst noted
Via Stocktwits · July 7, 2025
JP Power surged for a second straight session following acquisition buzz around parent JP Associates. An analyst flagged ₹20–₹23 as key levels, with valuation metrics indicating potential upside.
Via Stocktwits · July 7, 2025
Godrej Consumer Products surged 6% after a robust Q1 operational update. Brokerages retain ‘Buy’ calls, as double-digit growth potential emerges in both domestic and international markets.
Via Stocktwits · July 7, 2025
The stock is trading above all its key moving averages, indicating bullish momentum. The analyst projects a target of ₹590 by October.
Via Stocktwits · July 7, 2025
Technical indicators suggest a possible breakout setup for Arihant Capital. With Q1 results around the corner, an analyst is watching key levels.
Via Stocktwits · July 7, 2025
An analyst sees sustained buying interest near ₹1,650 with upside potential up to ₹1,775.
Via Stocktwits · July 7, 2025
An analyst has identified four Nifty 500 stocks showing bullish momentum, adding that these could be early-stage breakouts worth watching.
Via Stocktwits · July 7, 2025
An Xbox executive's suggestion that laid-off Microsoft employees use AI chatbots like ChatGPT for emotional support sparked backlash online, highlighting tensions as the company invests heavily in AI while cutting 9,100 jobs.
Via Benzinga · July 7, 2025
The stock could see a 35% upside at the upper end of the target price if it decisively breaks above ₹888, according to the analyst.
Via Stocktwits · July 7, 2025
The analyst is bullish on these two stocks, spotting breakout setups on their weekly charts. He expects a 35–40% rally in JK Paper and a potential uptrend in Ajanta Pharma.
Via Stocktwits · July 7, 2025
Dabur has broken past key resistance levels. The analyst suggests disciplined entries near ₹495–₹500 for swing traders.
Via Stocktwits · July 7, 2025
The markets remain rangebound, but their positive bias is intact, according to analysts. The index is building a higher low structure near 25,400.
Via Stocktwits · July 6, 2025
Via The Motley Fool · July 4, 2025
With a weekly close above ₹1,420, Kirloskar Pneumatic has entered a bullish zone, validating earlier expectations, according to the analyst.
Via Stocktwits · July 4, 2025
MGL shares have broken out of a multi-month resistance zone, signalling room for more gains. While the momentum is positive, RSI indicates the stock is in the overbought zone, the analyst said.
Via Stocktwits · July 4, 2025
Analysts see trend reversal signals in HBL Engineering and Indian Hume Pipe, while CreditAccess Grameen nears a critical resistance zone.
Via Stocktwits · July 4, 2025
Analysts are bullish on these stocks, citing strong RSI levels, moving average breakouts, and positive technical setups. All three stocks have posted double-digit gains so far in 2025.
Via Stocktwits · July 4, 2025
SBI is showing potential for fresh upside. Its technical charts are supported by robust long-term fundamentals, driven by a reduction of bad debts and rising credit demand.
Via Stocktwits · July 4, 2025
Technical indicators, such as MACD and RSI, are turning positive. The analyst suggests potential upside to ₹525.
Via Stocktwits · July 4, 2025
The stock has reached its extended Fibonacci target of ₹1,657, an ideal partial profit booking zone, the analyst said
Via Stocktwits · July 4, 2025
A SEBI probe found Jane Street used bearish options and large cash-market dumps to manipulate indices and profit massively. An analyst says the episode highlights why retail traders should avoid shortcuts and focus on disciplined investing.
Via Stocktwits · July 4, 2025
Despite an 8% drop in Trent, the analyst notes that higher highs and lows are forming on the chart. He suggests a buy with targets of ₹6,100 and ₹6,400.
Via Stocktwits · July 4, 2025
The stock could be seeing a potential trend reversal after declining more than 10% YTD
Via Stocktwits · July 4, 2025
Watch out for major block deals in Emcure and Piramal Pharmaceuticals
Via Stocktwits · July 3, 2025